Evaluation of Safety and Efficacy of Using Lipsus Device for Oral Wetting

NCT ID: NCT00945022

Last Updated: 2011-06-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-10-31

Study Completion Date

2012-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Following waking up from surgery performed under general anesthesia, patients are suffering from discomforting oral dryness, and moreover, they are not allowed drinking for 24 hours. The current management involves the wetting of patient's lips using wet bandage. This action is dependent on the presence of a family member or a nurse, which is not always possible. Many patients describe the oral dryness as a suffering, added to the suffering anyway entailed by surgery.

The investigated Lipsus device is intended for oral wetting, relieving patient's suffering and minimizing the dependence on continuous presence next to patient's bed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Oral Dryness General Surgery

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lipsus

Group Type EXPERIMENTAL

wetting lips following surgery using anesthesia

Intervention Type DEVICE

The investigator will position the Lipsus device in accordance with the instructions for use

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

wetting lips following surgery using anesthesia

The investigator will position the Lipsus device in accordance with the instructions for use

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject is scheduled for surgery under general anesthesia.
* Male/female age 18 and up.
* Subject able to comprehend and give informed consent for participation in this study
* Subject must sign the Informed Consent Form.

Exclusion Criteria

* Subjects who have any form of suspicious lesion in treatment target area.
* Pregnant or lactating Subjects
* Subjects with any infection / abscess / bleeding / blister / crack / edema / fissure / ulcer / pain in treatment target area.
* Eczema or dermatitis in treatment target area
* Subjects on drugs or psychologically determined unsuitable for the study.
* Subject is suffering extreme general weakness.
* Subject objects to the study protocol.
* Concurrent participation in any other clinical study
* Physician objection
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

IMD Tech Ltd

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

IMD Tech Ltd

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alexander Yuskavitch, Dr.

Role: PRINCIPAL_INVESTIGATOR

Shaari Zedek Medical Center, Jerusalem

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shaari Zedek Medical Center

Jerusalem, , Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hanna Levy, Dr

Role: CONTACT

(972)-4-638-8837

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hanna Levy, Dr.

Role: primary

(972)-4-638-8837

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

WL - 01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lollipop on Gastric Emptying
NCT04092049 COMPLETED NA